Alto Neuroscience, Inc. (ANRO)
15.13
+0.45
(+3.07%)
USD |
NYSE |
Dec 12, 16:00
15.14
+0.01
(+0.07%)
Pre-Market: 20:00
Alto Neuroscience Market Cap: 470.03M for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 171.10B |
| Eli Lilly & Co. | 919.64B |
| Pfizer Inc. | 146.98B |
| Brainstorm Cell Therapeutics, Inc. | 6.180M |
| CEL-SCI Corp. | 19.30M |
Market Cap Related Metrics
| PEG Ratio | -0.8354 |
| Price to Book Value | 4.213 |
| Price | 15.13 |
| Earnings Yield | -15.21% |
| PEGY Ratio | -0.8354 |